This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Nottingham. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Doug Forrester: Innovator in Biomarkers for Infection Detection
Introduction
Doug Forrester is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biomedical research, particularly in the detection of infections caused by Pseudomonas aeruginosa. His innovative work has implications for improving patient outcomes through early diagnosis.
Latest Patents
Doug Forrester holds a patent titled "Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof." This patent describes a method for determining the infection status of a subject by analyzing a sample of material obtained from them. The method involves determining the level of one or more alkyl quinolones or their metabolites produced by Pseudomonas aeruginosa or related species in the sample. This innovative approach has the potential to enhance diagnostic accuracy and treatment efficacy.
Career Highlights
Forrester's career is marked by his dedication to research and innovation in the biomedical field. He is affiliated with the University of Nottingham, where he collaborates with other researchers to advance the understanding of infectious diseases. His work has garnered attention for its practical applications in clinical settings.
Collaborations
Doug Forrester has worked alongside esteemed colleagues such as Miguel Camara and Paul Williams. These collaborations have fostered a productive research environment, leading to advancements in the detection and treatment of infections.
Conclusion
Doug Forrester's contributions to the field of infection detection through his innovative patent highlight the importance of research in improving healthcare outcomes. His work at the University of Nottingham continues to pave the way for advancements in biomedical diagnostics.